ALLISON BRATHWAITE DELPESCHE: Open Payments
NPI 1417515321 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 62 payments from 15 companies in 2025. Trend: 2023 $15 · 2024 $105 · 2025 $1,712
Food & beverage: $1,712
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $211 |
| Axsome Therapeutics, Inc. | 7 | $207 |
| E.R. Squibb & Sons, L.L.C. | 3 | $161 |
| Braeburn Inc. | 3 | $154 |
| Vanda Pharmaceuticals Inc. | 3 | $137 |
| Teva Pharmaceuticals USA, Inc. | 3 | $100 |
| Alkermes, Inc. | 5 | $96 |
| Neurocrine BioSciences, Inc. | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 3 | $91 |
Products named: VRAYLAR, CAPLYTA, Auvelity, COBENFY, BRIXADI, FANAPT, AUSTEDO XR, INGREZZA.
Industry payments across FL — which companies pay providers there.
